Get Live Data

Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally
Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globallyView Video
Firering Strategic Minerals : from explorer to producer
Firering Strategic Minerals: From explorer to producerView Video

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share Regulatory News
  5. GSK publishes provisional 2020 Dividend Dates

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,618.00
Bid: 1,615.00
Ask: 1,616.00
Change: 1.50 (0.09%)
Spread: 1.00 (0.062%)
Open: 1,619.50
High: 1,622.50
Low: 1,606.00
Prev. Close: 1,616.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GSK publishes provisional 2020 Dividend Dates

3 Feb 2020 15:15

RNS Number : 7940B
GlaxoSmithKline PLC
03 February 2020
 

GlaxoSmithKline plc

 

GSK publishes provisional dividend dates

 

 

 

The following amendment has been made to the 'GSK publishes 2020 Dividend Dates' announcement released on 8 January 2020 at 16:30 under RNS No 2038Z.

 

Q1 2020 Last date for DRIP elections amended to 18 June 2020.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

Results announcement date

Ex-dividend date

Record date

Last date for DRIP elections

Payment date

Q1 2020

Wednesday

29 April

Thursday

14 May

Friday

15 May

Thursday

18 June

Thursday

9 July

Q2 2020

Wednesday

29 July

Thursday

13 August

Friday

14 August

Thursday

17 September

Thursday

8 October

Q3 2020

Wednesday

28 October

Thursday

12 November

Friday

13 November

Monday

21 December

Thursday

14 January 2021

Q4 2020

(Final)

Wednesday

3 February 2021

Thursday

18 February 2021

Friday

19 February 2021

Tuesday

16 March 2021

Thursday

8 April 2021

 

These dates are indicative and may be subject to change.

 

 

 

 

Victoria Whyte

Company Secretary

 

3 February 2020

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCZXLFBBLLEBBK
34567891011
Date   Source Headline
8th Jul 20223:33 pmRNSDirector/PDMR Shareholding
8th Jul 20223:10 pmRNSDirector/PDMR Shareholding
6th Jul 20224:30 pmRNSResult of General Meeting
6th Jul 202210:11 amRNSDirector/PDMR Shareholding
5th Jul 202212:43 pmRNSGSK disclose discontinued operations from Q2 2022
5th Jul 20229:45 amRNSDirector/PDMR Shareholding
5th Jul 20229:30 amRNSDirector/PDMR Shareholding
1st Jul 20223:27 pmRNSTotal Voting Rights
1st Jul 20222:45 pmRNSGSK completes acquisition of Sierra Oncology
28th Jun 20225:56 pmRNSDirector/PDMR Shareholding
28th Jun 20227:00 amRNSGSK files Shingrix 18+ at risk indication in Japan
27th Jun 20224:08 pmRNSDirector/PDMR Shareholding
24th Jun 20223:44 pmRNSDirector/PDMR Shareholding
16th Jun 202210:58 amRNSDirector/PDMR Shareholding
10th Jun 20227:00 amRNSPositive phase III data for GSK’s RSV OA vaccine
9th Jun 20224:28 pmRNSDirector/PDMR Shareholding
7th Jun 20225:17 pmRNSDirector/PDMR Shareholding
7th Jun 202212:00 pmEQSHardman & Co Life Sciences Research: Long-term pharmaceutical industry cost and EBIT analysis
6th Jun 20227:00 amRNSUS FDA approval of Priorix
1st Jun 20224:55 pmRNSTotal Voting Rights
1st Jun 20221:00 pmRNSDemerger update: Publication of Documents
1st Jun 20227:00 amRNSDemerger update: Submission of Documents to FCA
31st May 20227:00 amRNSGSK to acquire Affinivax, Inc.
30th May 202210:00 amRNSFurther appointments to Designate Haleon Board
27th May 20227:00 amRNSGSK Cervarix two-dose schedule approved by NMPA
25th May 20223:41 pmPRNDirector/PDMR Shareholding
23rd May 20223:21 pmRNSDirector/PDMR Shareholding
19th May 202210:02 amRNSIain Mackay - External Appointment
16th May 20222:00 pmRNSChange of name to GSK plc
13th May 20225:13 pmRNSDirector/PDMR Shareholding
12th May 20228:58 amRNSDirector/PDMR Shareholding
11th May 20225:17 pmRNSBlock listing Interim Review
9th May 20222:53 pmRNSDirector/PDMR Shareholding
4th May 20225:49 pmRNSResult of AGM
4th May 202210:00 amRNSDirectorate Change
3rd May 20224:52 pmRNSTotal Voting Rights
27th Apr 20227:00 amRNS1st Quarter Results
26th Apr 20229:32 amRNSDirector/PDMR Shareholding
19th Apr 20227:00 amRNSDaprodustat application accepted for review by FDA
14th Apr 20222:23 pmRNSDirector/PDMR Shareholding
14th Apr 20222:15 pmRNSDirector/PDMR Shareholding
14th Apr 20221:29 pmRNSDirector/PDMR Shareholding
13th Apr 20225:11 pmRNSDirector/PDMR Shareholding
13th Apr 20229:32 amRNSDirector/PDMR Shareholding
13th Apr 20227:00 amRNSGSK agrees to acquire Sierra Oncology for $1.9bn
12th Apr 20225:10 pmRNSDirector/PDMR Shareholding
12th Apr 20224:23 pmRNSDirector/PDMR Shareholding
12th Apr 20224:00 pmRNSDirector/PDMR Shareholding
12th Apr 20223:48 pmRNSDirector/PDMR Shareholding
1st Apr 20224:03 pmRNSTotal Voting Rights
34567891011

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.